| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intracranial Aneurysm | 30 | 2020 | 53 | 10.210 |
Why?
|
| Stents | 27 | 2020 | 171 | 8.020 |
Why?
|
| Stroke | 40 | 2021 | 556 | 7.890 |
Why?
|
| Neurosurgery | 15 | 2020 | 35 | 7.180 |
Why?
|
| Thrombectomy | 27 | 2021 | 57 | 6.800 |
Why?
|
| Embolization, Therapeutic | 22 | 2020 | 82 | 5.710 |
Why?
|
| Cranial Sinuses | 9 | 2020 | 20 | 5.560 |
Why?
|
| Brain Ischemia | 22 | 2020 | 142 | 4.920 |
Why?
|
| Pseudotumor Cerebri | 7 | 2020 | 19 | 4.530 |
Why?
|
| Neurosurgical Procedures | 19 | 2020 | 92 | 4.070 |
Why?
|
| Aneurysm, Ruptured | 10 | 2020 | 25 | 3.630 |
Why?
|
| Physicians | 7 | 2020 | 142 | 3.290 |
Why?
|
| Burnout, Professional | 6 | 2020 | 43 | 3.240 |
Why?
|
| Humans | 138 | 2021 | 29002 | 3.020 |
Why?
|
| Internship and Residency | 10 | 2019 | 284 | 2.870 |
Why?
|
| Cerebral Angiography | 14 | 2020 | 50 | 2.710 |
Why?
|
| Treatment Outcome | 53 | 2021 | 3149 | 2.580 |
Why?
|
| Postoperative Complications | 14 | 2020 | 676 | 2.260 |
Why?
|
| Male | 82 | 2021 | 18242 | 2.190 |
Why?
|
| Female | 83 | 2021 | 18466 | 2.140 |
Why?
|
| Carotid Artery Diseases | 4 | 2018 | 122 | 2.100 |
Why?
|
| Periodicals as Topic | 6 | 2020 | 96 | 2.040 |
Why?
|
| Cerebrovascular Circulation | 5 | 2014 | 90 | 2.030 |
Why?
|
| Adult | 44 | 2020 | 8644 | 1.970 |
Why?
|
| Middle Aged | 62 | 2021 | 11242 | 1.960 |
Why?
|
| Carotid Artery, Internal | 3 | 2018 | 29 | 1.830 |
Why?
|
| Retrospective Studies | 37 | 2020 | 3074 | 1.820 |
Why?
|
| Prospective Studies | 21 | 2021 | 1989 | 1.690 |
Why?
|
| Venous Pressure | 3 | 2020 | 9 | 1.690 |
Why?
|
| Blood Vessel Prosthesis | 4 | 2020 | 79 | 1.570 |
Why?
|
| Manometry | 3 | 2019 | 23 | 1.500 |
Why?
|
| Job Satisfaction | 2 | 2020 | 35 | 1.490 |
Why?
|
| Carbon Dioxide | 2 | 2020 | 36 | 1.470 |
Why?
|
| Health Personnel | 2 | 2020 | 108 | 1.460 |
Why?
|
| Bibliometrics | 2 | 2019 | 8 | 1.410 |
Why?
|
| Cerebrovascular Disorders | 3 | 2018 | 53 | 1.400 |
Why?
|
| Evidence-Based Medicine | 5 | 2017 | 209 | 1.380 |
Why?
|
| Aged | 46 | 2021 | 9677 | 1.280 |
Why?
|
| Health Promotion | 3 | 2019 | 226 | 1.270 |
Why?
|
| Coronavirus Infections | 4 | 2020 | 72 | 1.270 |
Why?
|
| Pneumonia, Viral | 4 | 2020 | 77 | 1.270 |
Why?
|
| Fibrinolytic Agents | 6 | 2019 | 69 | 1.250 |
Why?
|
| Iatrogenic Disease | 4 | 2015 | 14 | 1.250 |
Why?
|
| Phlebography | 4 | 2020 | 26 | 1.250 |
Why?
|
| Workload | 3 | 2018 | 40 | 1.230 |
Why?
|
| Angiography | 5 | 2018 | 79 | 1.200 |
Why?
|
| Hospitalization | 7 | 2021 | 403 | 1.180 |
Why?
|
| Biomedical Research | 2 | 2017 | 164 | 1.150 |
Why?
|
| Intracranial Hypertension | 2 | 2018 | 21 | 1.150 |
Why?
|
| Healthcare Disparities | 3 | 2021 | 142 | 1.150 |
Why?
|
| United States | 17 | 2020 | 3701 | 1.120 |
Why?
|
| Thromboembolism | 3 | 2019 | 33 | 1.110 |
Why?
|
| Intracranial Hemorrhages | 4 | 2015 | 30 | 1.100 |
Why?
|
| Cerebral Revascularization | 6 | 2020 | 9 | 1.070 |
Why?
|
| Referral and Consultation | 3 | 2018 | 111 | 1.070 |
Why?
|
| Subarachnoid Hemorrhage | 5 | 2017 | 23 | 1.050 |
Why?
|
| Femoral Artery | 3 | 2020 | 44 | 1.050 |
Why?
|
| Insurance Coverage | 2 | 2015 | 72 | 1.050 |
Why?
|
| Decompression, Surgical | 3 | 2013 | 52 | 1.020 |
Why?
|
| Constriction, Pathologic | 5 | 2018 | 37 | 1.010 |
Why?
|
| Intracranial Pressure | 4 | 2019 | 17 | 1.000 |
Why?
|
| Retreatment | 3 | 2020 | 42 | 0.990 |
Why?
|
| Disease Management | 3 | 2019 | 126 | 0.990 |
Why?
|
| Medical Errors | 2 | 2014 | 37 | 0.950 |
Why?
|
| Accreditation | 2 | 2013 | 13 | 0.950 |
Why?
|
| Patient Selection | 4 | 2018 | 264 | 0.930 |
Why?
|
| Arterial Occlusive Diseases | 3 | 2016 | 31 | 0.890 |
Why?
|
| Personnel Staffing and Scheduling | 2 | 2012 | 20 | 0.890 |
Why?
|
| Mental Health | 3 | 2019 | 101 | 0.880 |
Why?
|
| Education, Medical, Graduate | 2 | 2013 | 117 | 0.870 |
Why?
|
| Efficiency | 2 | 2020 | 16 | 0.860 |
Why?
|
| Journal Impact Factor | 2 | 2019 | 8 | 0.850 |
Why?
|
| Aged, 80 and over | 21 | 2021 | 3728 | 0.840 |
Why?
|
| Anesthesia, General | 3 | 2020 | 32 | 0.830 |
Why?
|
| Attitude of Health Personnel | 2 | 2020 | 162 | 0.820 |
Why?
|
| Pilot Projects | 9 | 2020 | 465 | 0.810 |
Why?
|
| Physician's Role | 1 | 2020 | 44 | 0.780 |
Why?
|
| Central Nervous System Vascular Malformations | 3 | 2015 | 7 | 0.770 |
Why?
|
| Follow-Up Studies | 12 | 2020 | 2147 | 0.770 |
Why?
|
| Cerebral Arteries | 3 | 2016 | 17 | 0.760 |
Why?
|
| Ventriculostomy | 2 | 2017 | 11 | 0.740 |
Why?
|
| Thrombosis | 1 | 2019 | 56 | 0.730 |
Why?
|
| Tissue Plasminogen Activator | 5 | 2014 | 41 | 0.730 |
Why?
|
| Decompressive Craniectomy | 2 | 2016 | 5 | 0.730 |
Why?
|
| Drainage | 2 | 2017 | 51 | 0.720 |
Why?
|
| Superior Sagittal Sinus | 1 | 2018 | 6 | 0.720 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 135 | 0.710 |
Why?
|
| Intracranial Hypotension | 1 | 2018 | 3 | 0.710 |
Why?
|
| Transverse Sinuses | 1 | 2018 | 5 | 0.710 |
Why?
|
| Young Adult | 10 | 2020 | 2409 | 0.700 |
Why?
|
| Total Quality Management | 1 | 2018 | 19 | 0.690 |
Why?
|
| Quality of Life | 4 | 2020 | 854 | 0.690 |
Why?
|
| Aneurysm, False | 1 | 2018 | 13 | 0.690 |
Why?
|
| Vascular Diseases | 1 | 2018 | 62 | 0.680 |
Why?
|
| Radiography | 7 | 2014 | 348 | 0.680 |
Why?
|
| Surgical Flaps | 2 | 2016 | 84 | 0.670 |
Why?
|
| Middle Cerebral Artery | 4 | 2018 | 11 | 0.670 |
Why?
|
| Respiration, Artificial | 1 | 2018 | 98 | 0.670 |
Why?
|
| Neurology | 2 | 2020 | 39 | 0.660 |
Why?
|
| Neurosciences | 1 | 2017 | 8 | 0.660 |
Why?
|
| Hospitals | 2 | 2018 | 75 | 0.650 |
Why?
|
| Registries | 5 | 2021 | 288 | 0.630 |
Why?
|
| Infarction, Middle Cerebral Artery | 3 | 2017 | 12 | 0.630 |
Why?
|
| Prevalence | 5 | 2020 | 912 | 0.630 |
Why?
|
| Cooperative Behavior | 1 | 2017 | 77 | 0.630 |
Why?
|
| Trauma Centers | 2 | 2015 | 85 | 0.620 |
Why?
|
| Occupational Health Services | 1 | 2016 | 7 | 0.610 |
Why?
|
| Wakefulness | 1 | 2016 | 22 | 0.610 |
Why?
|
| Professional Misconduct | 1 | 2016 | 4 | 0.610 |
Why?
|
| Intracranial Arteriosclerosis | 2 | 2016 | 11 | 0.610 |
Why?
|
| Equipment and Supplies | 2 | 2015 | 15 | 0.610 |
Why?
|
| Cerebral Arterial Diseases | 1 | 2016 | 2 | 0.610 |
Why?
|
| Device Approval | 2 | 2015 | 6 | 0.610 |
Why?
|
| Skull | 1 | 2016 | 46 | 0.600 |
Why?
|
| Cerebral Infarction | 3 | 2016 | 24 | 0.600 |
Why?
|
| Occipital Bone | 2 | 2018 | 17 | 0.600 |
Why?
|
| Tremor | 1 | 2015 | 9 | 0.590 |
Why?
|
| Cervical Vertebrae | 2 | 2018 | 38 | 0.590 |
Why?
|
| Checklist | 2 | 2014 | 35 | 0.590 |
Why?
|
| Laminectomy | 2 | 2012 | 17 | 0.580 |
Why?
|
| Equipment Failure | 1 | 2015 | 20 | 0.580 |
Why?
|
| Microsurgery | 1 | 2015 | 22 | 0.580 |
Why?
|
| Functional Laterality | 1 | 2015 | 60 | 0.580 |
Why?
|
| Catheters, Indwelling | 1 | 2015 | 40 | 0.570 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2016 | 84 | 0.560 |
Why?
|
| Community Health Centers | 1 | 2015 | 13 | 0.560 |
Why?
|
| Physical Fitness | 1 | 2016 | 116 | 0.560 |
Why?
|
| Students, Medical | 1 | 2016 | 118 | 0.530 |
Why?
|
| Eponyms | 1 | 2014 | 3 | 0.530 |
Why?
|
| Anatomy | 1 | 2014 | 5 | 0.530 |
Why?
|
| Craniotomy | 2 | 2013 | 45 | 0.520 |
Why?
|
| Angioplasty | 1 | 2014 | 31 | 0.510 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2014 | 17 | 0.510 |
Why?
|
| Neuroanatomy | 1 | 2013 | 4 | 0.510 |
Why?
|
| Optic Nerve Diseases | 1 | 2013 | 12 | 0.490 |
Why?
|
| Thrombolytic Therapy | 3 | 2020 | 60 | 0.490 |
Why?
|
| Sagittal Sinus Thrombosis | 1 | 2013 | 1 | 0.490 |
Why?
|
| Cerebral Veins | 1 | 2013 | 11 | 0.480 |
Why?
|
| Ossification of Posterior Longitudinal Ligament | 1 | 2012 | 1 | 0.480 |
Why?
|
| Thalamus | 1 | 2013 | 41 | 0.470 |
Why?
|
| Patient Transfer | 2 | 2016 | 31 | 0.460 |
Why?
|
| Clinical Competence | 2 | 2013 | 304 | 0.460 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2020 | 454 | 0.460 |
Why?
|
| United States Food and Drug Administration | 1 | 2012 | 43 | 0.460 |
Why?
|
| Interdisciplinary Communication | 1 | 2012 | 53 | 0.450 |
Why?
|
| Monitoring, Intraoperative | 1 | 2012 | 40 | 0.450 |
Why?
|
| Wounds and Injuries | 1 | 2015 | 251 | 0.450 |
Why?
|
| Cerebral Hemorrhage | 3 | 2019 | 60 | 0.450 |
Why?
|
| Adolescent | 8 | 2020 | 3232 | 0.450 |
Why?
|
| Health Care Surveys | 2 | 2017 | 184 | 0.450 |
Why?
|
| Paraparesis | 1 | 2011 | 3 | 0.450 |
Why?
|
| Hyperparathyroidism | 1 | 2011 | 7 | 0.450 |
Why?
|
| Clinical Trials as Topic | 5 | 2015 | 308 | 0.450 |
Why?
|
| Solitary Fibrous Tumors | 1 | 2011 | 1 | 0.440 |
Why?
|
| Spinal Neoplasms | 1 | 2011 | 19 | 0.440 |
Why?
|
| Spinal Diseases | 1 | 2011 | 23 | 0.430 |
Why?
|
| Cohort Studies | 7 | 2020 | 1694 | 0.420 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2011 | 30 | 0.420 |
Why?
|
| Thoracic Vertebrae | 1 | 2011 | 42 | 0.420 |
Why?
|
| Spinal Fusion | 1 | 2011 | 43 | 0.420 |
Why?
|
| Sutures | 1 | 2011 | 16 | 0.420 |
Why?
|
| Vascular Surgical Procedures | 1 | 2012 | 93 | 0.420 |
Why?
|
| Risk Factors | 8 | 2021 | 3569 | 0.420 |
Why?
|
| Exercise | 1 | 2016 | 559 | 0.420 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2011 | 68 | 0.400 |
Why?
|
| Hematoma | 1 | 2010 | 23 | 0.400 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 202 | 0.400 |
Why?
|
| Joint Instability | 1 | 2011 | 61 | 0.400 |
Why?
|
| Abdominal Injuries | 1 | 2010 | 34 | 0.390 |
Why?
|
| Recovery of Function | 4 | 2020 | 228 | 0.390 |
Why?
|
| Publishing | 3 | 2020 | 57 | 0.380 |
Why?
|
| Single-Blind Method | 4 | 2016 | 170 | 0.380 |
Why?
|
| Penicillin G | 1 | 2009 | 3 | 0.370 |
Why?
|
| Neurosyphilis | 1 | 2009 | 3 | 0.370 |
Why?
|
| Reperfusion | 3 | 2020 | 16 | 0.370 |
Why?
|
| Ophthalmic Artery | 3 | 2014 | 9 | 0.370 |
Why?
|
| Tomography, X-Ray Computed | 6 | 2016 | 879 | 0.370 |
Why?
|
| Encephalitis | 1 | 2009 | 5 | 0.370 |
Why?
|
| Basilar Artery | 3 | 2018 | 8 | 0.350 |
Why?
|
| Pain | 1 | 2011 | 273 | 0.340 |
Why?
|
| Survival Rate | 4 | 2019 | 816 | 0.340 |
Why?
|
| Data Collection | 3 | 2013 | 171 | 0.340 |
Why?
|
| Vision, Ocular | 2 | 2020 | 21 | 0.330 |
Why?
|
| Databases, Factual | 5 | 2018 | 336 | 0.330 |
Why?
|
| Diagnosis, Differential | 3 | 2017 | 468 | 0.320 |
Why?
|
| Radial Artery | 2 | 2020 | 15 | 0.320 |
Why?
|
| Multicenter Studies as Topic | 4 | 2015 | 98 | 0.320 |
Why?
|
| Health Services Accessibility | 2 | 2018 | 232 | 0.310 |
Why?
|
| Polyvinyls | 2 | 2015 | 7 | 0.290 |
Why?
|
| Blood Pressure | 2 | 2020 | 858 | 0.270 |
Why?
|
| Intracranial Thrombosis | 2 | 2016 | 8 | 0.270 |
Why?
|
| Aneurysm | 2 | 2014 | 21 | 0.260 |
Why?
|
| Vision Disorders | 2 | 2014 | 20 | 0.250 |
Why?
|
| Emergency Service, Hospital | 1 | 2007 | 428 | 0.250 |
Why?
|
| Health Care Costs | 2 | 2015 | 103 | 0.250 |
Why?
|
| Hospital Mortality | 4 | 2021 | 190 | 0.250 |
Why?
|
| Brain Neoplasms | 3 | 2014 | 576 | 0.240 |
Why?
|
| Time Factors | 5 | 2020 | 2034 | 0.240 |
Why?
|
| Puerto Rico | 2 | 2012 | 11 | 0.230 |
Why?
|
| Child | 6 | 2020 | 2130 | 0.220 |
Why?
|
| Retinal Artery Occlusion | 1 | 2020 | 3 | 0.210 |
Why?
|
| Curriculum | 2 | 2013 | 192 | 0.210 |
Why?
|
| Carotid Stenosis | 1 | 2020 | 57 | 0.200 |
Why?
|
| Research | 1 | 2020 | 75 | 0.200 |
Why?
|
| Accidents, Traffic | 2 | 2014 | 179 | 0.190 |
Why?
|
| Universities | 1 | 2020 | 129 | 0.190 |
Why?
|
| Angioplasty, Balloon | 1 | 2019 | 33 | 0.190 |
Why?
|
| Risk Assessment | 3 | 2020 | 1319 | 0.190 |
Why?
|
| Arteriovenous Malformations | 1 | 2019 | 8 | 0.190 |
Why?
|
| Arteriovenous Fistula | 1 | 2019 | 13 | 0.180 |
Why?
|
| Personal Satisfaction | 1 | 2019 | 24 | 0.180 |
Why?
|
| Incidence | 3 | 2019 | 1097 | 0.180 |
Why?
|
| Child, Preschool | 3 | 2020 | 1156 | 0.180 |
Why?
|
| Paranasal Sinuses | 1 | 2018 | 5 | 0.180 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2018 | 7 | 0.180 |
Why?
|
| Scalp | 2 | 2015 | 33 | 0.170 |
Why?
|
| Mandibular Condyle | 1 | 2018 | 7 | 0.170 |
Why?
|
| Blister | 1 | 2018 | 7 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2014 | 1210 | 0.170 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 85 | 0.170 |
Why?
|
| Headache | 1 | 2018 | 81 | 0.170 |
Why?
|
| China | 1 | 2017 | 39 | 0.170 |
Why?
|
| Canada | 1 | 2017 | 49 | 0.170 |
Why?
|
| International Cooperation | 1 | 2017 | 25 | 0.170 |
Why?
|
| Neuronavigation | 1 | 2017 | 9 | 0.170 |
Why?
|
| Spinal Fractures | 1 | 2018 | 47 | 0.160 |
Why?
|
| Hydrocephalus | 1 | 2017 | 13 | 0.160 |
Why?
|
| United States Agency for Healthcare Research and Quality | 2 | 2013 | 5 | 0.160 |
Why?
|
| Physical Education and Training | 1 | 2016 | 11 | 0.160 |
Why?
|
| Feasibility Studies | 1 | 2017 | 255 | 0.150 |
Why?
|
| Jugular Veins | 1 | 2016 | 26 | 0.150 |
Why?
|
| South Carolina | 1 | 2016 | 31 | 0.150 |
Why?
|
| Linear Models | 2 | 2020 | 433 | 0.150 |
Why?
|
| Suction | 1 | 2016 | 14 | 0.150 |
Why?
|
| Algorithms | 3 | 2015 | 460 | 0.150 |
Why?
|
| Conscious Sedation | 1 | 2016 | 23 | 0.150 |
Why?
|
| Intraoperative Complications | 1 | 2016 | 50 | 0.150 |
Why?
|
| Schools, Medical | 1 | 2016 | 42 | 0.150 |
Why?
|
| Webcasts as Topic | 1 | 2016 | 3 | 0.150 |
Why?
|
| Infant | 2 | 2011 | 936 | 0.150 |
Why?
|
| Motor Skills | 1 | 2015 | 12 | 0.150 |
Why?
|
| Tantalum | 1 | 2015 | 3 | 0.140 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2015 | 10 | 0.140 |
Why?
|
| Information Dissemination | 1 | 2016 | 41 | 0.140 |
Why?
|
| Foreign-Body Migration | 1 | 2015 | 8 | 0.140 |
Why?
|
| Aneurysm, Infected | 1 | 2015 | 4 | 0.140 |
Why?
|
| Endocarditis | 1 | 2015 | 9 | 0.140 |
Why?
|
| Cerebellopontine Angle | 1 | 2015 | 3 | 0.140 |
Why?
|
| Rhabdomyosarcoma | 1 | 2015 | 6 | 0.140 |
Why?
|
| Sleep | 1 | 2016 | 86 | 0.140 |
Why?
|
| Neurilemmoma | 1 | 2015 | 14 | 0.140 |
Why?
|
| Cerebellar Neoplasms | 1 | 2015 | 11 | 0.140 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 890 | 0.140 |
Why?
|
| Vasoconstrictor Agents | 1 | 2015 | 62 | 0.140 |
Why?
|
| Equipment Design | 1 | 2015 | 175 | 0.130 |
Why?
|
| Pituitary Apoplexy | 1 | 2014 | 1 | 0.130 |
Why?
|
| Research Design | 1 | 2016 | 281 | 0.130 |
Why?
|
| Hematoma, Subdural, Acute | 1 | 2014 | 7 | 0.130 |
Why?
|
| Blindness | 1 | 2014 | 6 | 0.130 |
Why?
|
| Pituitary Neoplasms | 1 | 2014 | 17 | 0.130 |
Why?
|
| Malpractice | 1 | 2014 | 20 | 0.130 |
Why?
|
| Health Status | 1 | 2016 | 381 | 0.130 |
Why?
|
| Polyglycolic Acid | 1 | 2014 | 33 | 0.130 |
Why?
|
| Terminology as Topic | 1 | 2014 | 65 | 0.130 |
Why?
|
| Comorbidity | 2 | 2013 | 557 | 0.130 |
Why?
|
| Diagnostic Errors | 1 | 2014 | 41 | 0.130 |
Why?
|
| Endpoint Determination | 1 | 2013 | 18 | 0.130 |
Why?
|
| Models, Neurological | 1 | 2014 | 116 | 0.130 |
Why?
|
| Lactic Acid | 1 | 2014 | 55 | 0.130 |
Why?
|
| Work Schedule Tolerance | 1 | 2013 | 10 | 0.130 |
Why?
|
| Bayes Theorem | 1 | 2013 | 63 | 0.130 |
Why?
|
| Dilatation, Pathologic | 1 | 2013 | 18 | 0.120 |
Why?
|
| Polyesters | 1 | 2014 | 74 | 0.120 |
Why?
|
| User-Computer Interface | 1 | 2013 | 34 | 0.120 |
Why?
|
| Polymers | 1 | 2014 | 62 | 0.120 |
Why?
|
| Diet | 1 | 2016 | 345 | 0.120 |
Why?
|
| Quality Indicators, Health Care | 1 | 2013 | 57 | 0.120 |
Why?
|
| Prostheses and Implants | 1 | 2013 | 44 | 0.120 |
Why?
|
| Pneumonia | 1 | 2013 | 60 | 0.120 |
Why?
|
| Medicaid | 1 | 2013 | 79 | 0.120 |
Why?
|
| Inpatients | 1 | 2013 | 53 | 0.120 |
Why?
|
| Models, Theoretical | 1 | 2014 | 132 | 0.120 |
Why?
|
| Laboratory Personnel | 1 | 2012 | 1 | 0.120 |
Why?
|
| Personnel, Hospital | 1 | 2012 | 12 | 0.120 |
Why?
|
| African Americans | 1 | 2021 | 1571 | 0.120 |
Why?
|
| Nurses | 1 | 2012 | 14 | 0.120 |
Why?
|
| Computer Simulation | 1 | 2013 | 206 | 0.120 |
Why?
|
| Regional Blood Flow | 1 | 2012 | 85 | 0.110 |
Why?
|
| Feedback | 1 | 2012 | 33 | 0.110 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2012 | 56 | 0.110 |
Why?
|
| Osteitis Fibrosa Cystica | 1 | 2011 | 1 | 0.110 |
Why?
|
| Secondary Prevention | 1 | 2012 | 61 | 0.110 |
Why?
|
| Parathyroidectomy | 1 | 2011 | 10 | 0.110 |
Why?
|
| Treatment Failure | 1 | 2012 | 163 | 0.110 |
Why?
|
| Medicare | 1 | 2013 | 178 | 0.110 |
Why?
|
| Osteoclasts | 1 | 2011 | 22 | 0.110 |
Why?
|
| Antiparkinson Agents | 1 | 2011 | 8 | 0.110 |
Why?
|
| Quadriplegia | 1 | 2011 | 8 | 0.110 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 118 | 0.110 |
Why?
|
| Socioeconomic Factors | 1 | 2013 | 419 | 0.110 |
Why?
|
| Levodopa | 1 | 2011 | 12 | 0.110 |
Why?
|
| Preoperative Care | 1 | 2012 | 113 | 0.110 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2011 | 10 | 0.110 |
Why?
|
| Neurologic Examination | 1 | 2011 | 27 | 0.110 |
Why?
|
| Age Factors | 2 | 2013 | 1129 | 0.110 |
Why?
|
| Syndrome | 1 | 2011 | 67 | 0.110 |
Why?
|
| Deep Brain Stimulation | 1 | 2011 | 42 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2012 | 122 | 0.110 |
Why?
|
| Hemostasis, Surgical | 1 | 2011 | 13 | 0.110 |
Why?
|
| Anesthesia, Local | 1 | 2011 | 16 | 0.110 |
Why?
|
| Survival Analysis | 1 | 2012 | 448 | 0.110 |
Why?
|
| Parkinson Disease | 1 | 2011 | 54 | 0.100 |
Why?
|
| Educational Measurement | 1 | 2011 | 108 | 0.100 |
Why?
|
| Postoperative Care | 1 | 2011 | 75 | 0.100 |
Why?
|
| Drug Implants | 1 | 2010 | 7 | 0.100 |
Why?
|
| Hematoma, Subdural | 1 | 2010 | 12 | 0.100 |
Why?
|
| Paresis | 1 | 2010 | 14 | 0.100 |
Why?
|
| Reoperation | 1 | 2011 | 195 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 781 | 0.100 |
Why?
|
| Venous Thrombosis | 1 | 2010 | 50 | 0.100 |
Why?
|
| Disease Progression | 1 | 2012 | 596 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 376 | 0.100 |
Why?
|
| Longitudinal Studies | 1 | 2012 | 730 | 0.100 |
Why?
|
| Heparin | 1 | 2010 | 77 | 0.100 |
Why?
|
| Cognition | 1 | 2014 | 529 | 0.090 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2009 | 13 | 0.090 |
Why?
|
| Cholangiocarcinoma | 1 | 2009 | 17 | 0.090 |
Why?
|
| Pain Measurement | 1 | 2011 | 375 | 0.090 |
Why?
|
| Bile Duct Neoplasms | 1 | 2009 | 37 | 0.090 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 334 | 0.090 |
Why?
|
| Mississippi | 1 | 2007 | 23 | 0.080 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2018 | 66 | 0.080 |
Why?
|
| Hypertension | 3 | 2020 | 970 | 0.080 |
Why?
|
| Craniocerebral Trauma | 1 | 2007 | 56 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2009 | 283 | 0.080 |
Why?
|
| Acute Disease | 2 | 2019 | 248 | 0.070 |
Why?
|
| Rural Population | 1 | 2007 | 290 | 0.070 |
Why?
|
| Brain | 1 | 2012 | 956 | 0.070 |
Why?
|
| Data Interpretation, Statistical | 2 | 2013 | 106 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2016 | 539 | 0.060 |
Why?
|
| Internationality | 1 | 2021 | 21 | 0.050 |
Why?
|
| Quarantine | 1 | 2020 | 3 | 0.050 |
Why?
|
| Workflow | 1 | 2020 | 18 | 0.050 |
Why?
|
| Animals | 1 | 2013 | 7387 | 0.050 |
Why?
|
| Independent Living | 1 | 2020 | 60 | 0.050 |
Why?
|
| Catheterization, Peripheral | 1 | 2020 | 24 | 0.050 |
Why?
|
| Goals | 1 | 2020 | 31 | 0.050 |
Why?
|
| Forecasting | 1 | 2020 | 134 | 0.050 |
Why?
|
| Blood Pressure Determination | 1 | 2019 | 93 | 0.040 |
Why?
|
| Developing Countries | 1 | 2018 | 37 | 0.040 |
Why?
|
| Electric Impedance | 1 | 2018 | 14 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2019 | 521 | 0.040 |
Why?
|
| Triage | 1 | 2018 | 69 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2018 | 470 | 0.040 |
Why?
|
| Boston | 1 | 2016 | 17 | 0.040 |
Why?
|
| Massachusetts | 1 | 2016 | 28 | 0.040 |
Why?
|
| Verapamil | 1 | 2016 | 7 | 0.040 |
Why?
|
| Surgical Wound Infection | 1 | 2017 | 74 | 0.040 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 667 | 0.040 |
Why?
|
| Vasodilator Agents | 1 | 2016 | 56 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 1384 | 0.040 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2015 | 3 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2018 | 927 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2015 | 84 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 713 | 0.030 |
Why?
|
| Pulsatile Flow | 1 | 2014 | 25 | 0.030 |
Why?
|
| Time | 1 | 2013 | 23 | 0.030 |
Why?
|
| Health Facility Size | 1 | 2013 | 3 | 0.030 |
Why?
|
| Atlases as Topic | 1 | 2013 | 9 | 0.030 |
Why?
|
| Emergencies | 1 | 2013 | 48 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 2013 | 26 | 0.030 |
Why?
|
| Reference Standards | 1 | 2013 | 28 | 0.030 |
Why?
|
| Perfusion | 1 | 2012 | 64 | 0.030 |
Why?
|
| Sex Factors | 1 | 2013 | 652 | 0.030 |
Why?
|
| Aftercare | 1 | 2011 | 27 | 0.030 |
Why?
|
| Recurrence | 1 | 2011 | 236 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 302 | 0.020 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2009 | 7 | 0.020 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2009 | 29 | 0.020 |
Why?
|
| Endosonography | 1 | 2009 | 57 | 0.020 |
Why?
|
| Biopsy | 1 | 2009 | 240 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 453 | 0.020 |
Why?
|